http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9512403-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5d42f1fc507a639cdde6fc40d44954c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7da26cb077e35d67c7703ba5e49d7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7d74849c423f50755b34f8902f54561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e2f63bf494b2599ce8a4814720322f3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
filingDate 1994-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4d71e8b793d622b82382c1de8ee90a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d7be5e80ae3d47d5b4117067817075a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fdc6628f17210a4b7acef5789744a68
publicationDate 1995-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9512403-A1
titleOfInvention Use of low anticoagulant heparinderivatives
abstract The present invention relates to the use of low anticoagulant heparin (LA-heparin), low molecular weight-low anticoagulant heparin (LMW-LA-Heparin) or low anticoagulant heparan sulphate for the manufacture of a medicament regulating phospholipases A2 (PLA2). The medicament can be used against myotoxic phospholipases A2 (PLA2) and against bites from snakes or insects. The medicament also inhibits cellular PLA2 in human leukocytes and can be used for treating tissue damages caused by PLA2 and function as an anti-inflammatory medicament. The medicament can be adapted for injectable, topical or oral administration.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1003479-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1003479-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019185593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5767269-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763427-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6001820-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5744457-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352393-B2
priorityDate 1993-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4879282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9418988-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304

Total number of triples: 36.